Drug Patent Expirations in October 2013

Drug Patent Expirations for October 2013

Tradename Applicant Generic Name Patent Number Patent Expiration
OMNISCAN Ge Healthcare gadodiamide 5,560,903 Oct 1, 2013
ELOXATIN Sanofi Aventis Us oxaliplatin 5,338,874*PED Oct 7, 2013
LYRICA Pf Prism pregabalin 5,563,175 Oct 8, 2013
RESCRIPTOR Viiv Hlthcare delavirdine mesylate 5,563,142 Oct 8, 2013
RAXAR Otsuka grepafloxacin hydrochloride 5,563,138 Oct 8, 2013
JENLOGA Concordia Pharms Inc clonidine hydrochloride 5,869,100 Oct 13, 2013
KAPVAY Concordia Pharms Inc clonidine hydrochloride 5,869,100 Oct 13, 2013
PROPECIA Merck finasteride 5,547,957 Oct 15, 2013
STALEVO 100 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
STALEVO 150 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
COMTAN Orion Pharma entacapone 5,446,194 Oct 19, 2013
STALEVO 50 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
STALEVO 125 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
STALEVO 200 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
STALEVO 75 Orion Pharma carbidopa; entacapone; levodopa 5,446,194 Oct 19, 2013
LOTEMAX Pharmos loteprednol etabonate 5,540,930 Oct 25, 2013
MACUGEN Valeant Pharms Llc pegaptanib sodium 6,113,906 Oct 27, 2013
MACUGEN Valeant Pharms Llc pegaptanib sodium 5,919,455 Oct 27, 2013
BACTROBAN Glaxosmithkline mupirocin calcium 5,569,672 Oct 29, 2013
YAZ Bayer Hlthcare drospirenone; ethinyl estradiol 5,569,652 Oct 29, 2013
YASMIN Bayer Hlthcare drospirenone; ethinyl estradiol 5,569,652 Oct 29, 2013
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.
Contact Us with any questions.

Comments are closed.